Standing Committee of the National People's Congress, Decision on Extending the Period of Authorization of the State Council to Launch a Pilot Project for the Marketing Authorization Holder System in Certain Regions
全国人民代表大会常务委员会关于延长授权国务院在部分地方开展药品上市许可持有人制度试点期限的决定
November 14, 2018 | BY
Susan MokThe pilot period for the drug MAH scheme is extended
Adopted: October 26, 2018
Effective: November 5, 2018
Main contents: A one-year extension has been added to the three-year period for which the State Council was authorized to conduct a pilot project for the marketing authorization holder system in certain regions at the 17th Session of the Standing Committee of the 12th National People's Congress on November 4, 2015.
Related legislation: Decision on Authorizing the State Council to Launch a Pilot Project for the Marketing Authorization Holder System in Certain Regions and Relevant Issues Thereof, Official Reply on Matters Relevant to the Production and Distribution of Pharmaceuticals in the Pilot Marketing Authorization Holder Project, Plan for a Pilot Project for the Marketing Authorization Holder System for Pharmaceuticals and PRC Law on the Administration of Pharmaceuticals (2nd Revision)
This premium content is reserved for
China Law & Practice Subscribers.
A Premium Subscription Provides:
- A database of over 3,000 essential documents including key PRC legislation translated into English
- A choice of newsletters to alert you to changes affecting your business including sector specific updates
- Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
Already a subscriber? Log In Now